Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Mice with human chymase had a higher death rate when exposed to a toxin compared to normal mice.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Minoxidil lowers blood pressure in kids with kidney issues, but use carefully due to side effects.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

Seaweeds contain beneficial compounds with potential uses in food, cosmetics, and health, but more research is needed to improve extraction and safety.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Certain gene variations may increase the risk of hair loss in Egyptians.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Sarcoidosis can mimic other skin disorders, making diagnosis challenging.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Terbinafine can cause hair loss.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.